These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33537363)

  • 1. COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States.
    da Silva JF; Hernandez-Romieu AC; Browning SD; Bruce BB; Natarajan P; Morris SB; Gold JAW; Neblett Fanfair R; Rogers-Brown J; Rossow J; Szablewski CM; Oosmanally N; D'Angelo MT; Drenzek C; Murphy DJ; Hollberg J; Blum JM; Jansen R; Wright DW; Sewell W; Owens J; Lefkove B; Brown FW; Burton DC; Uyeki TM; Patel PR; Jackson BR; Wong KK
    Open Forum Infect Dis; 2021 Jan; 8(1):ofaa596. PubMed ID: 33537363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Prediction of Clinical Phenotypes in Hospitalized Patients With COVID-19: Machine Learning From Medical Records.
    Velez T; Wang T; Garibaldi B; Singman E; Koutroulis I
    JMIR Form Res; 2023 Oct; 7():e46807. PubMed ID: 37642512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program.
    Rao S; Jing N; Liu X; Lorman V; Maltenfort M; Schuchard J; Wu Q; Tong J; Razzaghi H; Mejias A; Lee GM; Pajor NM; Schulert GS; Thacker D; Jhaveri R; Christakis DA; Bailey LC; Forrest CB; Chen Y
    medRxiv; 2022 Sep; ():. PubMed ID: 36203555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological Characteristics of Hospitalized Patients with Moderate versus Severe COVID-19 Infection: A Retrospective Cohort Single Centre Study.
    Khamis F; Al Awaidy S; Shaaibi MA; Shukeili MA; Chhetri S; Balushi AA; Sulaimi SA; Balushi AA; Wesonga R
    Diseases; 2021 Dec; 10(1):. PubMed ID: 35076497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021.
    Melgar M; Abrams JY; Godfred-Cato S; Shah AB; Garg A; Strunk A; Narasimhan M; Koptyev J; Norden A; Musheyev D; Rashid F; Tannenbaum R; Estrada-Y-Martin RM; Patel B; Karanth S; Achenbach CJ; Hall GT; Hockney SM; Caputo M; Abbo LM; Beauchamps L; Morris S; Cifuentes RO; de St Maurice A; Bell DS; Prabaker KK; Sanz Vidorreta FJ; Bryant E; Cohen DK; Mohan R; Libby CP; SooHoo S; Domingo TJ; Campbell AP; Belay ED
    Clin Infect Dis; 2023 Nov; 77(10):1395-1405. PubMed ID: 37384794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication Profiles.
    Lusczek ER; Ingraham NE; Karam B; Proper J; Siegel L; Helgeson E; Lotfi-Emran S; Zolfaghari EJ; Jones E; Usher M; Chipman J; Dudley RA; Benson B; Melton GB; Charles A; Lupei MI; Tignanelli CJ
    medRxiv; 2020 Sep; ():. PubMed ID: 32995813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico.
    García-Alvarado FJ; Muñoz-Hernández MA; Moran Guel E; González-Martínez MDR; Macías Corral MA; Delgado-Aguirre HA
    Vector Borne Zoonotic Dis; 2021 Sep; 21(9):720-726. PubMed ID: 34255563
    [No Abstract]   [Full Text] [Related]  

  • 12. Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain.
    Rodríguez A; Ruiz-Botella M; Martín-Loeches I; Jimenez Herrera M; Solé-Violan J; Gómez J; Bodí M; Trefler S; Papiol E; Díaz E; Suberviola B; Vallverdu M; Mayor-Vázquez E; Albaya Moreno A; Canabal Berlanga A; Sánchez M; Del Valle Ortíz M; Ballesteros JC; Martín Iglesias L; Marín-Corral J; López Ramos E; Hidalgo Valverde V; Vidaur Tello LV; Sancho Chinesta S; Gonzáles de Molina FJ; Herrero García S; Sena Pérez CC; Pozo Laderas JC; Rodríguez García R; Estella A; Ferrer R;
    Crit Care; 2021 Feb; 25(1):63. PubMed ID: 33588914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretable clinical phenotypes among patients hospitalized with COVID-19 using cluster analysis.
    Yamga E; Mullie L; Durand M; Cadrin-Chenevert A; Tang A; Montagnon E; Chartrand-Lefebvre C; Chassé M
    Front Digit Health; 2023; 5():1142822. PubMed ID: 37114183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with poor outcomes among hospitalized patients with COVID-19: Experience from a MERS-CoV referral hospital.
    Barry M; Alotaibi M; Almohaya A; Aldrees A; AlHijji A; Althabit N; Alhasani S; Akkielah L; AlRajhi A; Nouh T; Temsah MH; Al-Tawfiq JA
    J Infect Public Health; 2021 Nov; 14(11):1658-1665. PubMed ID: 34627061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, Clinical Features, and Outcomes of Hospitalized Adults with COVID-19: Early Experience from an Academic Medical Center in Mississippi.
    Lucar J; Wingler MJB; Cretella DA; Ward LM; Sims Gomillia CE; Chamberlain N; Shimose LA; Brock JB; Harvey J; Wilhelm A; Majors LT; Jeter JB; Bueno MX; Albrecht S; Navalkele B; Mena LA; Parham J
    South Med J; 2021 Mar; 114(3):144-149. PubMed ID: 33655307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
    Ozonoff A; Schaenman J; Jayavelu ND; Milliren CE; Calfee CS; Cairns CB; Kraft M; Baden LR; Shaw AC; Krammer F; van Bakel H; Esserman DA; Liu S; Sesma AF; Simon V; Hafler DA; Montgomery RR; Kleinstein SH; Levy O; Bime C; Haddad EK; Erle DJ; Pulendran B; Nadeau KC; Davis MM; Hough CL; Messer WB; Higuita NIA; Metcalf JP; Atkinson MA; Brakenridge SC; Corry D; Kheradmand F; Ehrlich LIR; Melamed E; McComsey GA; Sekaly R; Diray-Arce J; Peters B; Augustine AD; Reed EF; Altman MC; Becker PM; Rouphael N;
    EBioMedicine; 2022 Sep; 83():104208. PubMed ID: 35952496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans.
    Ashktorab H; Pizuorno A; Adeleye F; Laiyemo A; Dalivand MM; Aduli F; Sherif ZA; Oskrochi G; Angesom K; Oppong-Twene P; Challa SR; Okorie N; Moon ES; Romos E; Jones-Wonni B; Kone AM; Rankine S; Thrift C; Scholes D; Ekwunazu C; Banson A; Mitchell B; Maskalo G; Ross J; Curtis J; Kim R; Gilliard C; Ahuja G; Mathew J; Gavin W; Kara A; Hache-Marliere M; Palaiodimos L; Mani VR; Kalabin A; Gayam VR; Garlapati PR; Miller J; Chirumamilla LG; Jackson F; Carethers JM; Kamangar F; Brim H
    BMC Infect Dis; 2022 Jun; 22(1):552. PubMed ID: 35715729
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.